CN205126899U - Sustainable and breast stable release pharmaceutical ingredients pastes - Google Patents
Sustainable and breast stable release pharmaceutical ingredients pastes Download PDFInfo
- Publication number
- CN205126899U CN205126899U CN201520863683.3U CN201520863683U CN205126899U CN 205126899 U CN205126899 U CN 205126899U CN 201520863683 U CN201520863683 U CN 201520863683U CN 205126899 U CN205126899 U CN 205126899U
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- releasing
- breast
- sustainable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The utility model discloses a sustainable and breast stable release pharmaceutical ingredients pastes, including the back sheet, the outside of back sheet is provided with a plurality of layers of traditional chinese medicine slowly -releasing grained layer to, in a plurality of layers of traditional chinese medicine slowly -releasing grained layer, use the back sheet to increase in proper order as starting point, the granule disintegrating time of traditional chinese medicine slowly -releasing grained layer. In addition, the outside of outermost traditional chinese medicine slowly -releasing grained layer still is provided with the protective layer. In addition, the material of back sheet, traditional chinese medicine slowly -releasing grained layer, protective layer is the aquogel colloid. The utility model discloses a set up the traditional chinese medicine slowly -releasing grained layer that granule disintegrating time increases in proper order to can realize that every A certain amount of time supplies with active ingredient to the skin, and then realize sustainable and stable supplying with active ingredient to the skin that great having avoided is once released active ingredient for load and injury that the skin brought in a large number, effectually increase therapeutical efficiency. Furthermore, the utility model discloses still has good biocompatibility, the reduction great to the sensitiveness of skin.
Description
Technical field
This utility model relates to medical art, specifically, relates to a kind of sustainable and breast of Stable Release ingredient and pastes.
Background technology
Breast is the suckling organ of women, simultaneously or women is important sexual organ, in two sexual activitys, occupies critical positions.But along with the development of society and the quickening of rhythm of life, the sickness rate of cyclomastopathy has the trend risen gradually.
At present, the diagnosis of cyclomastopathy has accounted for mammary gland special outpatient clinic patient's 60% ~ 80%, has also accounted for women's 20 ~ 40% in generaI investigation crowd." Chinese mastopathy investigation report " report display: in China city, the mortality rate of breast carcinoma increases 38.91%, and breast carcinoma has become and threatens maximum disease to WomanHealth, and breast cancer incidence occupies first of big city female tumor.In asymptomatic women crowd, various mastopathy patient reaches 52.4% unexpectedly, and this morbidity number is much higher than other chronic commonly encountered diseases of women and accounts for first place.Wherein only suffer from women's number of cyclomastopathy up to 49.7%.
Breast is all very important for each women, but the appearance of breast carcinoma but allows the breast of women enjoy threat.The annual newly-increased patient with breast cancer in the whole world reaches 1,200,000, and annual death toll reaches 500,000, and up-to-date medical information shows, China has nearly 200,000 women to die from the malignant tumor such as breast carcinoma every year, and China main cities nearly ten years sickness rate increases 37%.The whole world just has a women to be diagnosed as breast carcinoma for every 26 seconds.According to Ministry of Public Health data, every year because the women of breast cancer deaths just increases fast with the speed of 3%, become China's cancer that over nearly 10 years, mortality rate speedup is the fastest considerably beyond pulmonary carcinoma.Breast carcinoma has become " number one killer " of China women.
At present, what the conventional surgical Therapeutic Method for this kind of mastopathy of cyclomastopathy generally adopted is external use plaster, and external use plaster is then based on the form of plaster, the external use plaster poor air permeability of this patches, stick in health easily irritated, and dose can only disposablely ooze out, the load brought to skin is excessive with injury, and then causes therapeutic effect unsatisfactory, and easily causes other external complication.
For the problem in correlation technique, at present effective solution is not yet proposed.
Utility model content
For the problem in correlation technique, the utility model proposes a kind of sustainable and breast of Stable Release ingredient to paste, what it was sustainable and stable supplies effective ingredient to skin, add therapeutic efficiency greatly, avoid and once in a large number effective ingredient is discharged the load and injury that bring to skin.
The technical solution of the utility model is achieved in that
A kind of sustainable and breast of Stable Release ingredient pastes, comprise backing layer, the arranged outside of described backing layer has some layers of traditional Chinese medicine slow-releasing granular layer, and, in described some layers of traditional Chinese medicine slow-releasing granular layer, with described backing layer for starting point, the intragranular disintegration time of described traditional Chinese medicine slow-releasing granular layer increases successively.
Wherein, the intragranular disintegration time of described some layers of traditional Chinese medicine slow-releasing granular layer is that the mode of arithmetic progression increases progressively.
Preferably, the numerical value increased progressively described in is 3.
In addition, the outside of described outermost traditional Chinese medicine slow-releasing granular layer is also provided with protective layer.
In addition, the material of described backing layer, described traditional Chinese medicine slow-releasing granular layer, described protective layer is hydrogel colloid.
The beneficial effects of the utility model: by arranging the traditional Chinese medicine slow-releasing granular layer that the intragranular disintegration time increases successively, thus can realize every at regular intervals to skin supply effective ingredient, and then achieve sustainable and stable to skin supply effective ingredient, avoid greatly and once in a large number effective ingredient is discharged the load and injury that bring to skin, effectively add therapeutic efficiency.In addition, by the material adopting hydrogel colloid to paste as breast, thus make breast subsides have good biocompatibility, the sensitivity of skin is reduced greatly.
Accompanying drawing explanation
In order to be illustrated more clearly in this utility model embodiment or technical scheme of the prior art, be briefly described to the accompanying drawing used required in embodiment below, apparently, accompanying drawing in the following describes is only embodiments more of the present utility model, for those of ordinary skill in the art, under the prerequisite not paying creative work, other accompanying drawing can also be obtained according to these accompanying drawings.
Fig. 1 is according to a kind of sustainable of this utility model embodiment and the structural representation of the breast of Stable Release ingredient subsides.
In figure:
1, backing layer; 2, traditional Chinese medicine slow-releasing granular layer; 3, protective layer.
Detailed description of the invention
Below in conjunction with the accompanying drawing in this utility model embodiment, be clearly and completely described the technical scheme in this utility model embodiment, obviously, described embodiment is only this utility model part embodiment, instead of whole embodiments.Based on the embodiment in this utility model, the every other embodiment that those of ordinary skill in the art obtain, all belongs to the scope of this utility model protection.
According to embodiment of the present utility model, provide a kind of sustainable and breast of Stable Release ingredient and paste.
As shown in Figure 1, according to a kind of sustainable of this utility model embodiment and the breast of Stable Release ingredient paste, comprise backing layer 1, the arranged outside of described backing layer 1 has some layers of traditional Chinese medicine slow-releasing granular layer 2, and, in described some layers of traditional Chinese medicine slow-releasing granular layer 2, with described backing layer 1 for starting point, the intragranular disintegration time of described traditional Chinese medicine slow-releasing granular layer 2 increases successively.
In one embodiment, good sustainable and stable to skin supply effective ingredient in order to realize, the mode that the intragranular disintegration time of described some layers of traditional Chinese medicine slow-releasing granular layer 2 can be designed in arithmetic progression increases progressively, such as, increase progressively in the arithmetic progression mode that incremental value is 3 (hours), i.e. every 3 hours intragranular disintegration effective ingredient.
In one embodiment, in order to breast pastes easy to use, and be not easy to breakage or infringement effective ingredient, also can at the arranged outside protective layer of outermost traditional Chinese medicine slow-releasing granular layer 2, to protect Chinese medicine slow-releasing granules layer 2.
In one embodiment; stick after skin to prevent breast; there is the phenomenons such as poor air permeability, skin allergy; can be also hydrogel colloid by the material selection of backing layer 1, traditional Chinese medicine slow-releasing granular layer 2, protective layer 3; thus can effectively make breast subsides have good biocompatibility, the sensitivity of skin is reduced greatly.
When specifically using, the optional raw material with following percentage ratio in traditional Chinese medicine slow-releasing granular layer 2 is made: hydrogel 80 ~ 95%, germall BP0 ~ 0.5%, peony essential oil 0 ~ 0.5%, Semen Armeniacae Amarum quintessence oil 0 ~ 0.5%, Flos Carthami 0 ~ 1%, Chinese medicine adjuvant 2.5 ~ 17.5%.Wherein, Chinese medicine adjuvant can comprise: Radix Angelicae Sinensis 0.14 ~ 1%, Olibanum 0.07 ~ 0.5%, Radix Salviae Miltiorrhizae 0.14 ~ 1%, Fructus Liquidambaris 0.21 ~ 1.5%, Herba Menthae 0.07 ~ 0.5%, the Radix Astragali 0.14 ~ 1%, Rhizoma Polygoni Cuspidati 0.14 ~ 1%, Fructus Aurantii 0.14 ~ 1%, Herba Leonuri 0.14 ~ 1%, Placenta Hominis 0.14 ~ 1%, Fructus Cnidii 0.14 ~ 1%, Radix Dipsaci 0.07 ~ 0.5%, Semen Vaccariae 0.07 ~ 0.5%, Medulla Tetrapanacis 0.21 ~ 1.5%, Radix Trichosanthis 0.14 ~ 1%, Radix Arnebiae (Radix Lithospermi) 0.21 ~ 1.5%, Rhizoma Curcumae 0.14 ~ 1%, Ramulus et Folium Bauhiniae Faberi 0.07 ~ 0.5%, Flos Campsis 0.07 ~ 0.5%.
Corresponding, during embody rule, after making breast subsides by said ratio, breast is sticked after breast the preceding paragraph time, effect for the treatment of cyclomastopathy, breast nodule can be reached, and can promote that breast is strong, desalination nipple-areola pigmentation.
In sum, by means of technique scheme of the present utility model, by arranging the traditional Chinese medicine slow-releasing granular layer 2 that the intragranular disintegration time increases successively, thus can realize every at regular intervals to skin supply effective ingredient, and then achieve sustainable and stable to skin supply effective ingredient, avoid greatly and once in a large number effective ingredient is discharged the load and injury that bring to skin, effectively add therapeutic efficiency.In addition, by the material adopting hydrogel colloid to paste as breast, thus make breast subsides have good biocompatibility, the sensitivity of skin is reduced greatly.
The foregoing is only preferred embodiment of the present utility model; not in order to limit this utility model; all within spirit of the present utility model and principle, any amendment done, equivalent replacement, improvement etc., all should be included within protection domain of the present utility model.
Claims (5)
1. the sustainable and breast of Stable Release ingredient pastes, it is characterized in that, comprise backing layer, the arranged outside of described backing layer has some layers of traditional Chinese medicine slow-releasing granular layer, and, in described some layers of traditional Chinese medicine slow-releasing granular layer, with described backing layer for starting point, the intragranular disintegration time of described traditional Chinese medicine slow-releasing granular layer increases successively.
2. the sustainable and breast of Stable Release ingredient according to claim 1 pastes, and it is characterized in that, intragranular disintegration time of described some layers of traditional Chinese medicine slow-releasing granular layer is that the mode of arithmetic progression increases progressively.
3. the sustainable and breast of Stable Release ingredient according to claim 2 pastes, and it is characterized in that, described in the numerical value that increases progressively be 3.
4. the sustainable and breast of Stable Release ingredient according to claim 1 pastes, and it is characterized in that, the outside of described outermost traditional Chinese medicine slow-releasing granular layer is also provided with protective layer.
5. the sustainable and breast of Stable Release ingredient according to claim 4 pastes, and it is characterized in that, the material of described backing layer, described traditional Chinese medicine slow-releasing granular layer, described protective layer is hydrogel colloid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201520863683.3U CN205126899U (en) | 2015-11-03 | 2015-11-03 | Sustainable and breast stable release pharmaceutical ingredients pastes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201520863683.3U CN205126899U (en) | 2015-11-03 | 2015-11-03 | Sustainable and breast stable release pharmaceutical ingredients pastes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN205126899U true CN205126899U (en) | 2016-04-06 |
Family
ID=55612726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201520863683.3U Expired - Fee Related CN205126899U (en) | 2015-11-03 | 2015-11-03 | Sustainable and breast stable release pharmaceutical ingredients pastes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN205126899U (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498490A (en) * | 2018-05-22 | 2018-09-07 | 广州酷保生物科技有限公司 | It is a kind of virtue treat chest patch and preparation method thereof |
CN109432491A (en) * | 2018-11-12 | 2019-03-08 | 广州润虹医药科技股份有限公司 | A kind of slow release hemostatic gauze |
-
2015
- 2015-11-03 CN CN201520863683.3U patent/CN205126899U/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498490A (en) * | 2018-05-22 | 2018-09-07 | 广州酷保生物科技有限公司 | It is a kind of virtue treat chest patch and preparation method thereof |
CN109432491A (en) * | 2018-11-12 | 2019-03-08 | 广州润虹医药科技股份有限公司 | A kind of slow release hemostatic gauze |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101411848B (en) | Black plaster for treating gland hyperplasia and preparation method thereof | |
CN103386086B (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
CN104623512A (en) | Mammary gland hyperplasia emplastrum | |
CN100571753C (en) | A kind of antipsoriatics thing | |
CN205126899U (en) | Sustainable and breast stable release pharmaceutical ingredients pastes | |
CN102631624B (en) | Chinese herba external lotion for treating swelling of upper limb of affected side after breast cancer surgery | |
CN103341096B (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
CN103330849A (en) | Traditional Chinese medicine composition for treating psoriasis | |
CN100381155C (en) | Medicine for treating mammary glands hyperplasia | |
CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
CN102319317B (en) | Traditional Chinese medicine composition for treating menstrual disorder and preparation method thereof | |
CN101926857A (en) | Traditional Chinese medicinal liniment for treating vitiligo | |
CN101732478A (en) | Chinese medicament for treating constipation | |
CN100579542C (en) | Chinese medicinal herb formula for treating thrombocytopenia | |
CN100534495C (en) | Chinese herbal medicine paste for treating hard atrophic type dystrophy of vulva | |
CN101940624B (en) | Chinese medicinal lotion for treating vitiligo | |
CN101032573B (en) | Medicine for treating psoriasis and its preparing process | |
CN102423434A (en) | Medicament for treating eczema | |
CN103566115A (en) | Traditional Chinese medicine composition for treating arthralgia and myalgia | |
CN102228538A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
CN102357193A (en) | Traditional Chinese medicament for curing mammary hyperplasia | |
CN102283925A (en) | Traditional Chinese medicine for treating neurodynia resulted from herpes zoster | |
CN105343510A (en) | External traditional Chinese medicine composition for treating vulvar lichen sclerosus | |
CN104815056A (en) | Externally used traditional Chinese medicine for treating rheumatoid arthritis | |
CN105288443A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160406 Termination date: 20191103 |